Leadership

Clinicians, chemists, and operators—on one executive bench

Each role below owns a thread of the full chain: narrative, evidence, batch reality, and governance. Published profiles are shown where announced; other roles may remain in transition.

Vice President

Dahlia Miller, Vice President

Dahlia Miller

Vice President

Leads cross-functional innovation and commercialization of biotech-derived skincare technologies across North American and European markets. Oversees the company's science-driven product development strategy, aligning R&D with commercial growth to advance its women's skincare portfolio.

Dahlia Miller is a molecular and cellular biologist with extensive experience in biotechnology innovation, technology commercialization, and life sciences leadership. She holds a master's degree from the École Supérieure de Biotechnologie de Strasbourg (ESBS) and pursued doctoral studies in Bioengineering at the École Polytechnique Fédérale de Lausanne (EPFL). Before joining the company, she co-founded ExCellness Biotech SA, where she served as Chief Technology Officer and Chief Executive Officer. She also held leadership roles at Geneva University Hospitals (HUG), Innovaud, and Biopôle, driving innovation, technology transfer, strategic partnerships, and ecosystem development within the life sciences sector.

President & Chief Executive Officer

Anne-Renee Leyvraz, President & CEO

Anne-Renee Leyvraz

President & Chief Executive Officer

Leads clinical skincare operations and drives the refinement of personalized treatment protocols across the company's regional clinics, while advancing the brand's medical-grade skincare philosophy—integrating deep clinical expertise with patient-centric program execution to deliver tailored skin health solutions.

Anne-Renee Leyvraz is an experienced medical cosmetology expert with years of practice in the field. She is a graduate of a renowned medical school, with a solid foundation in medical expertise. She specializes in integrating medical cosmetology techniques with medical-grade cosmetics, and excels at customizing personalized skincare plans based on individual skin characteristics. She has made notable achievements in addressing skin aging and pigmentation issues, helping numerous clients achieve healthy and beautiful skin transformations.

Chief Medical & Innovation Officer

Sacha Sidjanski, Chief Medical & Innovation Officer

Sacha Sidjanski

Chief Medical & Innovation Officer

Leads product safety and efficacy research, drives the development of next-generation medical cosmetic formulations, and advances the company's evidence-based innovation pipeline—integrating clinical pharmacology expertise with regulatory compliance frameworks to deliver safer, more effective skincare solutions.

Sacha Sidjanski is an R&D medical consultant with deep expertise in medical cosmetics development. He holds an advanced degree in medicine and related fields, and has long been engaged in the research and development of medical cosmetics. His work focuses on active ingredient application and safety assessment. With extensive clinical experience and scientific research capabilities, he provides professional medical guidance for the company's product development, contributing to the creation of safer and more effective medical cosmetics and driving continuous innovation in the professional field.

Chief Operating Officer

Sofia Morel, Chief Operating Officer

Sofia Morel

Chief Operating Officer

Leads operations and drives expansion into North American and European markets while advancing the company's independent women's skincare brand—integrating management discipline with cross-regional program execution.

Sofia Morel brings over a decade of extensive experience in European market expansion. She earned a Bachelor of Business Administration from the Swiss Federal Institute of Technology in Lausanne in 2011. Throughout her career, she has helped internationally renowned brands such as Louis Vuitton, Burberry, L'Oréal, and Estée Lauder achieve strategic growth in major European markets including Italy, Spain, and France, as well as key Asia Pacific markets such as Tokyo, Singapore, Beijing, and Seoul.

In 2021, Sofia Morel joined Angel Medical Technology Company, where she leads the development of the independent women's skincare brand and drives the company's expansion into North American and European markets. As a representative of a new generation of independent female leaders, she has demonstrated exceptional capabilities in management, operations, and resource integration, delivering significant growth for the company.

Work with the same leadership bench

Commercial introductions route through one accountable office—whether you are shaping a new active narrative or industrializing a hero SKU.